Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Type of study
Publication year range
1.
Klin Khir ; (11-12): 76-8, 2010.
Article in Ukrainian | MEDLINE | ID: mdl-21268804

ABSTRACT

The results of prostaglandin E1 et systemic antibacterial therapy use in 1836 patients, suffering purulent-necrotic affection of foot, were summarized. There was established, that cefuroxym constitutes the first line preparation for the ostheoarthropathy focus elimination, when the affection is limited and the patient state is stable, and meronem--for extended affection and unstable patient's state. In the pronounced ischemia of the foot the initial administration of cefepim is the most effective. For purulent-necrotic affection as a consequence of the foot wounding, erysipelas or operative intervention it is expedient to use carbapenem or meropenem. The systemic antibacterial therapy administration had promoted significant reduction of the treatment duration and improvement of its result.


Subject(s)
Alprostadil/therapeutic use , Anti-Bacterial Agents/therapeutic use , Diabetes Mellitus, Type 1/complications , Diabetes Mellitus, Type 2/complications , Diabetic Foot/drug therapy , Adult , Aged , Aged, 80 and over , Alprostadil/administration & dosage , Anti-Bacterial Agents/administration & dosage , Diabetes Mellitus, Type 1/drug therapy , Diabetes Mellitus, Type 1/microbiology , Diabetes Mellitus, Type 1/pathology , Diabetes Mellitus, Type 1/surgery , Diabetes Mellitus, Type 2/drug therapy , Diabetes Mellitus, Type 2/microbiology , Diabetes Mellitus, Type 2/pathology , Diabetes Mellitus, Type 2/surgery , Diabetic Foot/etiology , Diabetic Foot/microbiology , Diabetic Foot/pathology , Diabetic Foot/surgery , Drug Therapy, Combination , Female , Humans , Male , Microbial Sensitivity Tests , Middle Aged , Necrosis , Treatment Outcome , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...